David R. Walt, Director at Cerulean Pharma Inc. (CERU), bought 18,000 shares at $2.47 ($44K) on 2016-01-27, disclosed to the SEC on 2016-01-29.
Open-market purchase of $44k CERU by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.47 | 4,500 | $11K | 25.1% |
| 2 | $2.47 | 4,500 | $11K | 25.1% |
| 3 | $2.45 | 4,500 | $11K | 24.9% |
| 4 | $2.45 | 4,500 | $11K | 24.9% |
| Total | $2.46 avg | 18,000 | $44K | 100% |
| Filing → |
| QTRX | BUY | 2024-09-17 | $625K | — | Filing → |
| QTRX | BUY | 2022-08-10 | $2.6M | — | Filing → |
| QTRX | BUY | 2020-03-17 | $1.8M | — | Filing → |